Matteo Bellucci

Matteo Bellucci has a diverse work experience in the scientific field. Matteo began their career as a PhD student at the University of Bologna, where their research focused on UreE from Helicobacter pylori. Matteo explored the biochemical, structural, and metal binding properties of UreE, as well as its interaction with the related chaperone UreG. After completing their PhD, Matteo worked as a postdoctoral researcher at the Center for Genomic Regulation (CRG), studying macromolecular interactions involving long non-coding RNAs and proteins. Matteo used in vitro and in vivo experiments, as well as in silico prediction methods, to investigate the functional roles of these interactions in neurological diseases. Matteo then moved on to a position as a postdoctoral researcher at CNRS, where they focused on understanding the functional interactions between co-translational modifying enzymes and E. coli ribosomes. Matteo'sresearch aimed to characterize the physical interactions between ribosomes and ribosome-associated protein biogenesis factors, and how they are regulated. After this, Matteo worked as a postdoctoral researcher at ESPCI, where they worked on droplet-based microfluidics for HIV vaccine development and the selection of neutralizing HIV antibodies. Matteo screened HIV envelope protein variants for stability of neutralizing epitopes and absence of non-neutralizing epitopes. Matteo then transitioned to the role of a Protein Scientist at the Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, where their research focused on proteins. Most recently, they have been working as a Production Chemist at BioPorto Diagnostics A/S. Currently, Matteo holds the position of Tech Transfer Scientist at Bavarian Nordic.

Matteo Bellucci completed their Bachelor Degree in Biotechnology from the University of Bologna, where they studied from 2001 to 2004. Matteo then pursued their graduate studies at Alma Mater Studiorum – Università di Bologna, earning a graduate degree in an undisclosed field of study, which they completed in 2006.